Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

60,745 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy, safety and immunogenicity of hexavalent rotavirus vaccine in Chinese infants.
Wu Z, Li Q, Liu Y, Lv H, Mo Z, Li F, Yu Q, Jin F, Chen W, Zhang Y, Huang T, Hu X, Xia W, Gao J, Zhou H, Bai X, Liu Y, Liang Z, Jiang Z, Chen Y, Zhang J, Du J, Yang B, Xing B, Xing Y, Dong B, Yang Q, Shi C, Yan T, Ruan B, Shi H, Fan X, Feng D, Lv W, Zhang D, Kong X, Zhou L, Que D, Chen H, Chen Z, Guo X, Zhou W, Wu C, Zhou Q, Liu Y, Qiao J, Wang Y, Li X, Duan K, Zhao Y, Xu G, Yang X. Wu Z, et al. Among authors: li f, li x, li q. Virol Sin. 2022 Oct;37(5):724-730. doi: 10.1016/j.virs.2022.07.011. Epub 2022 Aug 1. Virol Sin. 2022. PMID: 35926726 Free PMC article. Clinical Trial.
Clinical evaluation of the lot-to-lot consistency of an enterovirus 71 vaccine in a commercial-scale phase IV clinical trial.
Chen J, Jin P, Chen X, Mao Q, Meng F, Li X, Chen W, Du M, Gao F, Liu P, Li X, Guo C, Xie T, Lu W, Li Q, Li L, Yan X, Guo X, Du H, Li X, Duan K, Zhu F. Chen J, et al. Among authors: li x, li l, li q. Hum Vaccin Immunother. 2022 Nov 30;18(5):2063630. doi: 10.1080/21645515.2022.2063630. Epub 2022 Jun 17. Hum Vaccin Immunother. 2022. PMID: 35714273 Free PMC article. Clinical Trial.
Safety and Immunogenicity of an Inactivated COVID-19 Vaccine, WIBP-CorV, in Healthy Children: Interim Analysis of a Randomized, Double-Blind, Controlled, Phase 1/2 Trial.
Xia S, Duan K, Zhang Y, Zeng X, Zhao D, Zhang H, Xie Z, Li X, Peng C, Zhang W, Yang Y, Chen W, Gao X, You W, Wang X, Wang Z, Shi Z, Wang Y, Yang X, Li Q, Huang L, Wang Q, Lu J, Yang Y, Guo J, Zhou W, Wan X, Wu C, Wang W, Huang S, Du J, Nian X, Deng T, Yuan Z, Shen S, Guo W, Liu J, Yang X. Xia S, et al. Among authors: li x, li q. Front Immunol. 2022 Jun 24;13:898151. doi: 10.3389/fimmu.2022.898151. eCollection 2022. Front Immunol. 2022. PMID: 35812412 Free PMC article. Clinical Trial.
Immunogenicity and safety of an enterovirus 71 vaccine in children aged 36-71 months: A double-blind, randomised, similar vaccine-controlled, non-inferiority phase III trial.
Tong Y, Zhang X, Chen J, Chen W, Wang Z, Li Q, Duan K, Wei S, Yang B, Qian X, Li J, Hang L, Deng S, Li X, Guo C, Shen H, Liu Y, Deng P, Xie T, Li Q, Li L, Du H, Mao Q, Gao F, Lu W, Guan X, Huang J, Li X, Chen X. Tong Y, et al. Among authors: li j, li x, li l, li q. EClinicalMedicine. 2022 Jul 29;52:101596. doi: 10.1016/j.eclinm.2022.101596. eCollection 2022 Oct. EClinicalMedicine. 2022. PMID: 35923425 Free PMC article.
Safety and immunogenicity of rabies vaccine (PVRV-WIBP) in healthy Chinese aged 10-50 years old: Randomized, blinded, parallel controlled phase III clinical study.
Huang X, Liang J, Huang L, Nian X, Chen W, Zhang J, Xu X, Lin X, Wang Y, Shi J, Jia L, Li Q, Wang Q, Duan K, Li X, Ji Y, Peng F, Zhang W, Xie Z, Wang Y, Yang X. Huang X, et al. Among authors: li x, li q. Hum Vaccin Immunother. 2023 Dec 31;19(1):2211896. doi: 10.1080/21645515.2023.2211896. Epub 2023 May 30. Hum Vaccin Immunother. 2023. PMID: 37249318 Free PMC article. Clinical Trial.
Immunogenicity and safety of a new hexavalent rotavirus vaccine in Chinese infants: A randomized, double-blind, placebo-controlled phase 2 clinical trial.
Wu ZW, Jin F, Li QL, Gao JM, Zhou HS, Duan K, Gao Z, Liu Y, Hao ZY, Chen W, Liu YY, Xu GL, Yang B, Dong B, Zhang JW, Zhao YL, Yang XM. Wu ZW, et al. Hum Vaccin Immunother. 2023 Aug;19(2):2263228. doi: 10.1080/21645515.2023.2263228. Epub 2023 Oct 16. Hum Vaccin Immunother. 2023. PMID: 37843437 Free PMC article. Clinical Trial.
Human monoclonal antibody F61 nasal spray effectively protected high-risk populations from SARS-CoV-2 variants during the COVID-19 pandemic from late 2022 to early 2023 in China.
Liu Y, Zhang J, Liu W, Pan Y, Ruan S, Nian X, Chen W, Sun L, Yin Q, Yue X, Li Q, Gui F, Wu C, Wang S, Yang Y, Jing Z, Long F, Wang Z, Zhang Z, Huang C, Duan K, Liang M, Yang X. Liu Y, et al. Among authors: li q. Emerg Microbes Infect. 2024 Dec;13(1):2284297. doi: 10.1080/22221751.2023.2284297. Epub 2024 Mar 26. Emerg Microbes Infect. 2024. PMID: 37970736 Free PMC article. Clinical Trial.
60,745 results
You have reached the last available page of results. Please see the User Guide for more information.